From
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy Treatment Decision-making at the Time of Suspected BCR after Primary RP (2024)
"
Guideline Statements
Treatment Decision-making at the Time of Suspected BCR after Primary RP1. Clinicians should inform patients that salvage radiation for a detectable prostate-specific antigen (PSA) after RP is more effective when given at lower levels of PSA. (Strong Recommendation; Evidence Level: Grade B)
2. For patients with a detectable PSA after RP in whom salvage RT is being considered, clinicians should provide salvage radiation when the PSA is ≤ 0.5 ng/mL. (Moderate Recommendation; Evidence Level: Grade B)
3. For patients with a detectable PSA after RP who are at high risk for clinical progression, clinicians may offer salvage radiation when PSA values are < 0.2 ng/mL. (Conditional Recommendation; Evidence Level: Grade C)
____________________
Table 1. - High-risk Features in the Setting of BCR to be Considered for Patient Counseling and Management /a/
• Grade Group 4-5
• Stage pT3b-4
• Surgical margin status /b/
• Node-positive disease
• Short PSA doubling time (PSADT)
• Short interval from primary therapy to PSA recurrence (including persistent detectable PSA after prostatectomy)
• Higher post-prostatectomy PSA
• Genomic classifier risk
• PET imaging findings
____________________
/a/ The Panel recognizes that the above does not represent an exhaustive list of relevant prognostic variables.
/b/ Of note, the presence of positive surgical margins has been associated both with an increased likelihood of BCR as well as a lower risk of disease progression after salvage radiation."
_____________________________________________________
[From Part 1 of 3 Parts]
Note how the above Recommendations go from Strong to Moderate to Conditional. We have to keep in mind that for evidence-based medicine, not all the evidence is equally strong.
If you think of each of the parameters in Table 1 as a toggle or slider on some master control panel, the difficulty of decision-making for many men becomes apparent.
While I and my uro are familiar with the factors that will go into any decision for salvage therapy that I may need (Table 1) and the suggested PSA thresholds (above and elsewhere), my uro and I decided it was time to consult with an R.O. to do the hard part: weigh all the factors for
my particular case, synthesizing and applying their knowledge of the salvage-therapy literature, their clinical experience, and their institutional results (Duke in my case) to best counsel me.